The pattern recognition receptor PTX3 is recruited at the synapse between dying and dendritic cells, and edits the cross-presentation of self, viral, and tumor antigens

被引:83
作者
Baruah, P
Propato, A
Dumitriu, IE
Rovere-Querini, P
Russo, V
Fontana, R
Accapezzato, D
Peri, G
Mantovani, A
Barnaba, V
Manfredi, AA
机构
[1] H San Raffaele Inst, Dept Biotechnol, Canc Immunotherapy & Gene Therapy Program, Clin Immunol Unit, I-20132 Milan, Italy
[2] H San Raffaele Inst, Canc Gene Therapy Unit, I-20132 Milan, Italy
[3] Univ Roma La Sapienza, Dipartimento Med Interna, Fdn Andrea Cesalpino, Rome, Italy
[4] Mario Negri Inst Pharmacol Res, Milan, Italy
[5] Ist Clin Humaitas, Rozzano, Italy
[6] Univ Milan, Ctr Eccellenza Innovaz Diagnost & Terapeut, Inst Gen Pathol, Milan, Italy
[7] Univ Vita Salute San Raffaele, Milan, Italy
[8] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy
关键词
D O I
10.1182/blood-2005-03-1112
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pentraxins are soluble pattern recognition receptors with a dual role: protection against extracellular microbes and autoimmunity. The mechanisms by which they accomplish these tasks are not yet fully understood. Here we show that the prototypic long pentraxin PTX3 is specifically recruited at both sides of the phagocytic synapse between dendritic cells (DCs) and dying cells and remains stably bound to the apoptotic membranes (estimated half-time > 36 hours). Apoptotic cells per se influence the production of PTX3 by maturing DCs. When both microbial stimuli and dying cells are present, PTX3 behaves as a flexible adaptor of DC function, regulating the maturation program and the secretion of soluble factors. Moreover a key event associated with autoimmunity (ie, the cross-presentation of epitopes expressed by apoptotic cells to T cells) abates in the presence of PTX3, as evaluated using self, viral, and tumor-associated model antigens (vinculin, NS3, and MelanA/MART1). In contrast, PTX3 did not influence the presentation of exogenous soluble antigens, an event required for immunity against extracellular pathogens. These data suggest that PTX3 acts as a third-party agent between microbial stimuli and dying cells, contributing to limit tissue damage under inflammatory conditions and the activation of autoreactive T cells.
引用
收藏
页码:151 / 158
页数:8
相关论文
共 70 条
  • [1] Transdifferentiation of preadipose cells into smooth muscle-like cells: role of aortic carboxypeptidase-like protein
    Abderrahim-Ferkoune, A
    Bezy, O
    Astri-Roques, S
    Elabd, C
    Ailhaud, G
    Amri, EZ
    [J]. EXPERIMENTAL CELL RESEARCH, 2004, 293 (02) : 219 - 228
  • [2] Cellular mechanisms governing cross-presentation of exogenous antigens
    Ackerman, AL
    Cresswell, P
    [J]. NATURE IMMUNOLOGY, 2004, 5 (07) : 678 - 684
  • [3] Selective induction of pentraxin 3, a soluble innate immune pattern recognition receptor, in infectious episodes in patients with haematological malignancy
    al-Ramadi, BK
    Ellis, M
    Pasqualini, F
    Mantovani, A
    [J]. CLINICAL IMMUNOLOGY, 2004, 112 (03) : 221 - 224
  • [4] Opinion - Death-defying immunity: do apoptotic cells influence antigen processing and presentation?
    Albert, ML
    [J]. NATURE REVIEWS IMMUNOLOGY, 2004, 4 (03) : 223 - 231
  • [5] ALLES VV, 1994, BLOOD, V84, P3483
  • [6] SELECTIVE KILLING OF HEPATITIS-B ENVELOPE ANTIGEN-SPECIFIC B-CELLS BY CLASS-I-RESTRICTED, EXOGENOUS ANTIGEN-SPECIFIC LYMPHOCYTES-T
    BARNABA, V
    FRANCO, A
    ALBERTI, A
    BENVENUTO, R
    BALSANO, F
    [J]. NATURE, 1990, 345 (6272) : 258 - 260
  • [7] Bellone M, 1997, J IMMUNOL, V159, P5391
  • [8] CROSS-PRIMING FOR A SECONDARY CYTOTOXIC RESPONSE TO MINOR H-ANTIGENS WITH H-2 CONGENIC CELLS WHICH DO NOT CROSS-REACT IN CYTOTOXIC ASSAY
    BEVAN, MJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 143 (05) : 1283 - 1288
  • [9] Significant (re)location: how to use chromatin and/or abundant proteins as messages of life and death
    Bianchi, ME
    [J]. TRENDS IN CELL BIOLOGY, 2004, 14 (06) : 287 - 293
  • [10] Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo
    Bondanza, A
    Zimmermann, VS
    Rovere-Querini, P
    Turnay, J
    Dumitriu, IE
    Stach, CM
    Voll, RE
    Gaipl, US
    Bertling, W
    Pöschl, E
    Kalden, JR
    Manfredi, AA
    Herrmann, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (09) : 1157 - 1165